What is SuO-Val-Cit-PAB-MMAE used for in research?

SuO-Val-Cit-PAB-MMAE is a potent cytotoxic payload used in antibody-drug conjugates (ADCs) for cancer therapy. It is linked to antibodies that target cancer cells, delivering the MMAE toxin to induce cell death.

How does SuO-Val-Cit-PAB-MMAE function in ADCs?

The Val-Cit peptide linker in SuO-Val-Cit-PAB-MMAE is cleaved by proteases in cancer cells, releasing MMAE (monomethyl auristatin E) to disrupt microtubules and induce apoptosis.

What type of cancer therapies can SuO-Val-Cit-PAB-MMAE be integrated into?

SuO-Val-Cit-PAB-MMAE is primarily used in antibody-drug conjugates (ADCs) for targeted cancer therapies. It is effective in treating cancers with specific surface markers, such as lymphoma and breast cancer.

How does SuO-Val-Cit-PAB-MMAE compare to other MMAE-based ADCs?

SuO-Val-Cit-PAB-MMAE offers high potency with a cleavable Val-Cit linker, similar to other MMAE-based ADCs, but Creative Biolabs' version ensures high purity and optimized conjugation efficiency for research applications.

What cell lines are suitable for testing SuO-Val-Cit-PAB-MMAE?

SuO-Val-Cit-PAB-MMAE is commonly tested on cancer cell lines that express specific surface markers targeted by ADCs, such as HER2-positive or CD30-positive cell lines in cancer research.

SuO-Val-Cit-PAB-MMAE (CAT#: ADC-S-077)

Linker-Toxin SET, this set is made by MMAE conjugated to the lysosomally cleavable SuO-Val-Cit-PAB linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate.

Product Information

Description
Linker-Toxin SET, this set is made by MMAE conjugated to the lysosomally cleavable SuO-Val-Cit-PAB linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate.

Molecular Weight
1264.51

Purity
95%

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

CAMouse™-Fully Human Antibody Generation Platform

Reviews

Literature

Protocol

Customer Reviews and FAQs

There are currently no Customer reviews or questions for ADC-S-077. Click the button above to contact us or submit your feedback about this product.

Customer Reviews FAQ

Excellent

Creative Biolabs' SuO-Val-Cit-PAB-MMAE proved to be a highly effective ADC payload. The compound's stability and specific action on tumor cells greatly improved our targeted therapy experiments.

Excellent

We've had consistent success with Creative Biolabs' SuO-Val-Cit-PAB-MMAE. The compound provided effective and controlled cytotoxicity in our experiments, making it a top choice for our ADC development.

Excellent

Creative Biolabs' SuO-Val-Cit-PAB-MMAE has been a reliable asset in our research. The linker-drug combination ensured targeted action, resulting in enhanced cytotoxicity in our cancer cell assays.

Excellent

Using SuO-Val-Cit-PAB-MMAE from Creative Biolabs yielded impressive results in our lab. Its controlled drug release and potency were crucial for effective antibody-drug conjugate design and performance.

Excellent

SuO-Val-Cit-PAB-MMAE from Creative Biolabs delivered outstanding performance in our ADC research. The linker-drug system showed excellent stability and targeted cytotoxicity, enhancing the precision of our cancer cell studies.

Q: 1: What is SuO-Val-Cit-PAB-MMAE used for in research?
A: SuO-Val-Cit-PAB-MMAE is a potent cytotoxic payload used in antibody-drug conjugates (ADCs) for cancer therapy. It is linked to antibodies that target cancer cells, delivering the MMAE toxin to induce cell death.
Q: 2: How does SuO-Val-Cit-PAB-MMAE function in ADCs?
A: The Val-Cit peptide linker in SuO-Val-Cit-PAB-MMAE is cleaved by proteases in cancer cells, releasing MMAE (monomethyl auristatin E) to disrupt microtubules and induce apoptosis.
Q: 3: What type of cancer therapies can SuO-Val-Cit-PAB-MMAE be integrated into?
A: SuO-Val-Cit-PAB-MMAE is primarily used in antibody-drug conjugates (ADCs) for targeted cancer therapies. It is effective in treating cancers with specific surface markers, such as lymphoma and breast cancer.
Q: 4: How does SuO-Val-Cit-PAB-MMAE compare to other MMAE-based ADCs?
A: SuO-Val-Cit-PAB-MMAE offers high potency with a cleavable Val-Cit linker, similar to other MMAE-based ADCs, but Creative Biolabs' version ensures high purity and optimized conjugation efficiency for research applications.
Q: 5: What cell lines are suitable for testing SuO-Val-Cit-PAB-MMAE?
A: SuO-Val-Cit-PAB-MMAE is commonly tested on cancer cell lines that express specific surface markers targeted by ADCs, such as HER2-positive or CD30-positive cell lines in cancer research.

Quick Links

ADC Toxins

Drug-linker Complexes

Customized ADCs

Anti-Ab ADCs

For Research Use Only. NOT FOR CLINICAL USE.

Online Inquiry

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.